文献速递白血病

治疗相关与原发性成人B细胞急性淋巴细胞白血病的比较研究

Comparative study of therapy-related and de novo adult b-cell acute lymphoblastic leukaemia.
PubMed 文献 · Br J Haematol · 2021-10-25

该研究比较了331例B-ALL患者中69例(21%)治疗相关ALL(tr-ALL)与原发性ALL的差异。tr-ALL患者更年长、女性更多、低二倍体核型更常见,完全缓解率更低且MRD阳性率更高,但诊断后总生存和异基因造血干细胞移植后生存相似。

要点

  • tr-ALL占B-ALL的21%,常见既往肿瘤为乳腺癌和浆细胞疾病。
  • tr-ALL患者更年长、女性居多,低二倍体核型比例更高。
  • tr-ALL完全缓解率更低、MRD阳性率更高,但总生存相似。

核心结论

  • tr-ALL与原发性B-ALL在临床特征和缓解深度上存在差异,但诊断后总生存和移植后生存相似。

研究设计与样本

  • 回顾性比较分析331例B-ALL患者,其中69例(21%)为治疗相关ALL。

主要发现

  • tr-ALL与原发性ALL诊断后总生存及异基因造血干细胞移植后生存相似。

临床怎么用

  • 对tr-ALL患者应预期较低完全缓解率和较高MRD阳性率,需加强MRD监测。
  • tr-ALL患者可考虑异基因造血干细胞移植,因移植后生存与原发性ALL相似。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We report a comparative analysis of patients with therapy-related acute lymphoblastic leukaemia (tr-ALL) vs de novo ALL. We identified 331 patients with B-ALL; 69 (21%) were classified as tr-ALL. The most common prior malignancies were breast (23·2%) and plasma cell disorders (20·3%). Patients with tr-ALL were older (median 63·2 vs. 46·2 years, P < 0.001), more often female (66·7% vs. 43·5%, P < 0·001), and more likely to have hypodiploid cytogenetics (18·8% vs. 5·0%, P < 0·001). In multivariable analysis, patients with tr-ALL were less likely to achieve complete remission [odds ratio (OR) = 0·16, P < 0·001] and more likely to be minimal residual disease-positive (OR = 4·86, P = 0·01) but had similar OS after diagnosis and allo-haematopoietic cell transplantation.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Abdel Rahman ZH, Parrondo RD, Heckman MG, et al. Comparative study of therapy-related and de novo adult b-cell acute lymphoblastic leukaemia. Br J Haematol. 2021. PMID: 34697797. doi:10.1111/bjh.17906

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。